{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT03150511","recordId":"NCT03150511","peptideSlug":"tesamorelin","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03150511-tesamorelin/","json":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct03150511.json","markdown":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct03150511.md"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2017-05-09","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2017-05-09","publishedAt":"2026-08-23","recordId":"NCT03150511","recordSha256":"e2c332aaedfe89baf7539fe276e46ff8649357bad52b43cc85dd8a2f56fae09e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03150511?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Description","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2018-02-13","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2018-02-13","publishedAt":"2026-08-23","recordId":"NCT03150511","recordSha256":"e84394272212165fc5ff66585a9f65d6b2c93d9ab1d536f1bf26532fa8609ac9","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03150511?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2018-05-22","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2018-05-22","publishedAt":"2026-08-23","recordId":"NCT03150511","recordSha256":"de1d1a437c3686f30ea623cc34eb6fb0cc3ee9038c31e647d17bb49b5f5f5796","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03150511?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2018-07-12","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2018-07-12","publishedAt":"2026-08-23","recordId":"NCT03150511","recordSha256":"d70db16e095712caa48c96b14ee8651c3c652781183c41549f5a46ef23f8b34c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03150511?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Identification","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2019-02-07","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2019-02-07","publishedAt":"2026-08-23","recordId":"NCT03150511","recordSha256":"41e913a97f04e56e3dbb0b0abd31d19df38984155db9e147e03b67a51c64d27e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03150511?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Identification","Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2019-05-09","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2019-05-09","publishedAt":"2026-08-23","recordId":"NCT03150511","recordSha256":"e329745b8ade8021f1be7b02db3a895e430570e4df10c04ec2bf0ba87eebe005","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03150511?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Sponsor/Collaborators","Study Identification","Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2020-05-19","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2020-05-19","publishedAt":"2026-08-23","recordId":"NCT03150511","recordSha256":"db2fceb71ceb815e6aa023c8ab33fd209f8094847098b62064d3045ba7326ba1","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03150511?a=7&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":8,"lastUpdateSubmitQcDate":"2020-12-08","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2020-12-08","publishedAt":"2026-08-23","recordId":"NCT03150511","recordSha256":"c0fff8afc9ef8f9862d661c79af5f00797aaa58a9aa55bbc850bacf3375458ff","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03150511?a=8&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":9,"lastUpdateSubmitQcDate":"2021-12-07","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2021-12-07","publishedAt":"2026-08-23","recordId":"NCT03150511","recordSha256":"649c2ff774d1cbfde1c6f9aeb19c05ee9f9bea7d11061a38488b43343f2ff106","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03150511?a=9&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Eligibility","Outcome Measures","Study Status"],"historyVersion":10,"lastUpdateSubmitQcDate":"2022-12-06","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2022-12-06","publishedAt":"2026-08-23","recordId":"NCT03150511","recordSha256":"40b81b0c89c379bf6a161ef8284b2b76bfad649dc43c3132e9ceac96a5b5aebb","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03150511?a=10&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Outcome Measures","Study Identification","Study Status"],"historyVersion":11,"lastUpdateSubmitQcDate":"2023-08-08","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2023-08-08","publishedAt":"2026-08-23","recordId":"NCT03150511","recordSha256":"d805c497d06796c67accf8fba4232da8a82f013f872d3fe02bc6a610b83e7d16","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03150511?a=11&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":12,"lastUpdateSubmitQcDate":"2024-09-04","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2024-09-04","publishedAt":"2026-08-23","recordId":"NCT03150511","recordSha256":"38d314146b0ea3d320faba27626033778b6d402201c3ff9026ae64047a351ba4","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03150511?a=12&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Arms and Interventions","Outcome Measures","Study Description","Study Status"],"historyVersion":13,"lastUpdateSubmitQcDate":"2024-11-08","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2024-11-08","publishedAt":"2026-08-23","recordId":"NCT03150511","recordSha256":"607ea2a2a8db86d65dacc6768b4bb6a3752d76d5bf8f7612466c83333772dc00","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03150511?a=13&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":14,"lastUpdateSubmitQcDate":"2025-11-10","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2025-11-10","publishedAt":"2026-08-23","recordId":"NCT03150511","recordSha256":"1764ff87f83c14fe0e29b404cd422ea5e369a436969b17a6e80fcb25d676eb55","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03150511?a=14&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"74bed4b409532d9e825965174588100affabb5b923ede54fc5a398f8902c7a4c"}}